Matches in Wikidata for { <http://www.wikidata.org/entity/Q94355553> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q94355553 description "article scientifique publié en 2005" @default.
- Q94355553 description "wetenschappelijk artikel" @default.
- Q94355553 description "наукова стаття" @default.
- Q94355553 name "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 name "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 type Item @default.
- Q94355553 label "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 label "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 prefLabel "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 prefLabel "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 P1433 Q94355553-533336B7-7B9D-4B2D-ADA2-7975CCB46158 @default.
- Q94355553 P1476 Q94355553-1E27B00D-0427-457F-80E8-7C040A8F31F2 @default.
- Q94355553 P2093 Q94355553-35F99D0E-EB9C-41B1-BE6F-C5E552AA4FF4 @default.
- Q94355553 P2093 Q94355553-CB4E5B59-2315-4E0B-9C4D-26FEBBBF8D89 @default.
- Q94355553 P2283 Q94355553-DDC035F0-6E1F-42D0-9282-C51B4ED4C875 @default.
- Q94355553 P304 Q94355553-B6630A29-7266-4CC0-B965-B6C432D5A68D @default.
- Q94355553 P31 Q94355553-AF3CE73A-EAA7-4B63-BA89-712741F17669 @default.
- Q94355553 P356 Q94355553-8085CC5E-898F-4FD5-A153-D4D82F53F781 @default.
- Q94355553 P433 Q94355553-C17595BD-53C6-4417-8182-5293D23B2EBF @default.
- Q94355553 P478 Q94355553-F449EC36-7D41-48F6-A10B-71ABDAAA7631 @default.
- Q94355553 P577 Q94355553-9D9FAC32-12BC-4845-B922-D61203558941 @default.
- Q94355553 P921 Q94355553-152090C0-8D79-4A9E-80FA-CC015031C334 @default.
- Q94355553 P921 Q94355553-1CA2DB25-EAB9-42E8-8FD7-8DF9F97AF54C @default.
- Q94355553 P921 Q94355553-2CD3453E-8F1F-40A6-95AA-745E099551EF @default.
- Q94355553 P921 Q94355553-91A1CE7E-F419-448D-AD78-018EB123D153 @default.
- Q94355553 P932 Q94355553-A284B08B-7A1D-4F30-90B6-74F89423BA31 @default.
- Q94355553 P356 BCR1244 @default.
- Q94355553 P1433 Q2208481 @default.
- Q94355553 P1476 "A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)" @default.
- Q94355553 P2093 "A Bensalem" @default.
- Q94355553 P2093 "K Bouzid" @default.
- Q94355553 P2283 Q1231081 @default.
- Q94355553 P304 "P10-P10" @default.
- Q94355553 P31 Q13442814 @default.
- Q94355553 P356 "10.1186/BCR1244" @default.
- Q94355553 P433 "Suppl 1" @default.
- Q94355553 P478 "7" @default.
- Q94355553 P577 "2005-05-27T00:00:00Z" @default.
- Q94355553 P921 Q1231081 @default.
- Q94355553 P921 Q12859063 @default.
- Q94355553 P921 Q18936 @default.
- Q94355553 P921 Q42824440 @default.
- Q94355553 P932 "4231924" @default.